Gastrointestinal Cancer News and Research

RSS
Gastrointestinal cancer refers to malignant conditions of the gastrointestinal tract, including the esophagus, stomach, liver, biliary system, pancreas, bowels, and anus.
China CDC signs collaborative agreement with Hutchinson Cancer Research Center

China CDC signs collaborative agreement with Hutchinson Cancer Research Center

ACOG joins Jay Monahan Center to develop new chapter on Female Cancers resource guide

ACOG joins Jay Monahan Center to develop new chapter on Female Cancers resource guide

US Oncology enrolls 1,000th patient in Phase I clinical trial

US Oncology enrolls 1,000th patient in Phase I clinical trial

Micromet to initiate MEDI-565 Phase 1 trial in patients with advanced gastrointestinal cancer

Micromet to initiate MEDI-565 Phase 1 trial in patients with advanced gastrointestinal cancer

BCM-95 curcumin exhibits anti-inflammatory properties

BCM-95 curcumin exhibits anti-inflammatory properties

ESMO honors three eminent cancer specialists for their contribution towards medical research

ESMO honors three eminent cancer specialists for their contribution towards medical research

ESMO honors eminent cancer specialists

ESMO honors eminent cancer specialists

US oncology announces its contributions in development of 42 novel cancer therapies

US oncology announces its contributions in development of 42 novel cancer therapies

Proton therapy treatment for anal canal cancer performed for first time in US

Proton therapy treatment for anal canal cancer performed for first time in US

Data on activity of Nektar's NKTR-102 in gastrointestinal cancer presented at ESMO 12th World Congress

Data on activity of Nektar's NKTR-102 in gastrointestinal cancer presented at ESMO 12th World Congress

Combination of Biothera's Imprime PGG and Erbitux doubles response rate in colorectal cancer patients

Combination of Biothera's Imprime PGG and Erbitux doubles response rate in colorectal cancer patients

Afinitor more than doubles progression-free survival in advanced pancreatic NET: Study

Afinitor more than doubles progression-free survival in advanced pancreatic NET: Study

Ph II data of perifosine + capecitabine in metastatic CRC to be presented at gastrointestinal cancer congress

Ph II data of perifosine + capecitabine in metastatic CRC to be presented at gastrointestinal cancer congress

Nektar commences dosing in Phase 1 study of NKTR-102 in combination with 5-FU/leucovorin

Nektar commences dosing in Phase 1 study of NKTR-102 in combination with 5-FU/leucovorin

New presentations on neuroendocrine tumors at ESMO 12th World Congress on Gastrointestinal Cancer

New presentations on neuroendocrine tumors at ESMO 12th World Congress on Gastrointestinal Cancer

Alnylam presents interim data from ALN-VSP02 Phase I trial for liver cancer at ASCO 2010

Alnylam presents interim data from ALN-VSP02 Phase I trial for liver cancer at ASCO 2010

New research to improve treatment for oesophageal and upper stomach cancer

New research to improve treatment for oesophageal and upper stomach cancer

Researchers investigate aberrant expression of nuclear matrix proteins in gastric cancer cells

Researchers investigate aberrant expression of nuclear matrix proteins in gastric cancer cells

Infinity Pharmaceuticals initiates Phase 1b/2 trial of IPI-926 Hedgehog pathway inhibitor for pancreatic cancer

Infinity Pharmaceuticals initiates Phase 1b/2 trial of IPI-926 Hedgehog pathway inhibitor for pancreatic cancer

Aptium Oncology Myeloma Consortium launched

Aptium Oncology Myeloma Consortium launched